These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34299194)

  • 21. Runx transcription factors repress human and murine c-Myc expression in a DNA-binding and C-terminally dependent manner.
    Jacobs PT; Cao L; Samon JB; Kane CA; Hedblom EE; Bowcock A; Telfer JC
    PLoS One; 2013; 8(7):e69083. PubMed ID: 23874874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.
    Teppo S; Laukkanen S; Liuksiala T; Nordlund J; Oittinen M; Teittinen K; Grönroos T; St-Onge P; Sinnett D; Syvänen AC; Nykter M; Viiri K; Heinäniemi M; Lohi O
    Genome Res; 2016 Nov; 26(11):1468-1477. PubMed ID: 27620872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
    PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLI1 is associated with regulation of DNA methylation and megakaryocytic differentiation in FPDMM caused by a RUNX1 transactivation domain mutation.
    Tanaka Y; Nakanishi Y; Furuhata E; Nakada KI; Maruyama R; Suzuki H; Suzuki T
    Sci Rep; 2024 Jun; 14(1):14080. PubMed ID: 38890442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
    Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
    Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression.
    Fuka G; Kauer M; Kofler R; Haas OA; Panzer-Grümayer R
    PLoS One; 2011; 6(10):e26348. PubMed ID: 22028862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
    Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
    Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definition of a small core transcriptional circuit regulated by AML1-ETO.
    Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW
    Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.
    Landrette SF; Madera D; He F; Castilla LH
    Leukemia; 2011 Apr; 25(4):655-62. PubMed ID: 21263445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells.
    Wesely J; Kotini AG; Izzo F; Luo H; Yuan H; Sun J; Georgomanoli M; Zviran A; Deslauriers AG; Dusaj N; Nimer SD; Leslie C; Landau DA; Kharas MG; Papapetrou EP
    Cell Rep; 2020 Jun; 31(9):107688. PubMed ID: 32492433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma.
    Van Roosbroeck K; Cox L; Tousseyn T; Lahortiga I; Gielen O; Cauwelier B; De Paepe P; Verhoef G; Marynen P; Vandenberghe P; De Wolf-Peeters C; Cools J; Wlodarska I
    Blood; 2011 Apr; 117(15):4056-64. PubMed ID: 21325169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
    Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
    J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.
    Kantner HP; Warsch W; Delogu A; Bauer E; Esterbauer H; Casanova E; Sexl V; Stoiber D
    Neoplasia; 2013 Nov; 15(11):1292-300. PubMed ID: 24339741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.
    Challen GA; Goodell MA
    Exp Hematol; 2010 May; 38(5):403-16. PubMed ID: 20206228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity.
    Weng S; Matsuura S; Mowery CT; Stoner SA; Lam K; Ran D; Davis AG; Lo MC; Zhang DE
    Leukemia; 2017 Jan; 31(1):159-169. PubMed ID: 27389055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RUNX1-RUNX1 homodimerization modulates RUNX1 activity and function.
    Li D; Sinha KK; Hay MA; Rinaldi CR; Saunthararajah Y; Nucifora G
    J Biol Chem; 2007 May; 282(18):13542-51. PubMed ID: 17355962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
    Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
    Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells.
    Sakai I; Kraft AS
    J Biol Chem; 1997 May; 272(19):12350-8. PubMed ID: 9139679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.